Keep buying on Ranbaxy Laboratories with a target price of Rs 585.Ranbaxy has entered into agreements with Pfizer Inc to settle patent litigation worldwide involving Lipitor in US ( USD 8 billion) and 7 other countries (USD 2.5 billion). The settlement also involves Caduet USD 400 million (combination of Atorvastatin and Amlodipine).
Friday, June 20, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment